山东大学耳鼻喉眼学报 ›› 2015, Vol. 29 ›› Issue (5): 47-49.doi: 10.6040/j.issn.1673-3770.0.2015.150

• 论著 • 上一篇    下一篇

D-二聚体与鼻咽癌预后的关系

车娟1, 赵洪春1, 李金玲2, 王延飞1   

  1. 1. 滨州医学院附属医院耳鼻咽喉科, 山东 滨州 256603;
    2. 滨州医学院附属医院检验科, 山东 滨州 256603
  • 收稿日期:2015-04-09 修回日期:2015-07-09 出版日期:2015-10-16 发布日期:2015-10-16
  • 通讯作者: 王延飞,E-mail:cjbanana@163.com E-mail:cjbanana@163.com
  • 作者简介:车娟,E-mail:13375438181@163.com

The relationship between D-Dimer and nasopharyngeal carcinoma

CHE Juan1, ZHAO Hongchun1, LI Jinling2, WANG Yanfei1   

  1. 1. Department of Otolaryngology, the Affiliated Hospital of Binzhou Medical University, Binzhou 256603, Shandong, China;
    2. Department of Laboratory Medicine, the Affiliated Hospital of Binzhou Medical University, Binzhou 256603, Shandong, China
  • Received:2015-04-09 Revised:2015-07-09 Online:2015-10-16 Published:2015-10-16

摘要: 目的 研究D-二聚体判断鼻咽癌预后的价值。方法 2009年1月至2012年12月前瞻性地比较了69例初诊鼻咽癌患者和69例健康个体就诊时的血浆D-二聚体水平,分析了鼻咽癌患者血浆D-二聚体水平与其临床分期的关系。采用受试者工作特征(ROC)曲线法和Kaplan-Meier法分析鼻咽癌患者D-二聚体与患者全因死亡率的关系。结果 鼻咽癌患者血浆D-二聚体水平显著高于健康个体。随着鼻咽癌分期的递进,患者血浆D-二聚体水平逐渐增高。D-二聚体预测患者死亡的ROC曲线下面积为0.72。二聚体高于0.55 mg/L的患者全因死亡的风险明显高于D-二聚体低于0.55 mg/L的患者。结论 D-二聚体是鼻咽癌的预后指标,其增高提示患者预后不良。

关键词: 预后, D-二聚体, 鼻咽癌

Abstract: Objective To investigate the prognostic value of plasma D-dimer for nasopharyngeal carcinoma. Method Sixty-nine nasopharyngeal carcinoma patients and their gender-and age-matched healthy individuals were prospectively enrolled, and their plasma D-Dimer on admission were compared. The association between plasma D-Dimer and clinical stage of nasopharyngeal carcinoma was analyzed. The prognostic value of D-dimer for all-cause mortality was estimated by receiver operating characteristic (ROC) curves and Kaplan-Meier approach. Results Compared with healthy individuals, nasopharyngeal patients had significantly higher plasma D-dimer. Plasma D-Dimer increased as the advance of clinical stage of nasopharyngeal carcinoma. The area under ROC curve of plasma D-Dimer for all-cause mortality was 0.72. Patients with increased D-Dimer (more than 0.55 mg/L) have higher risk of death than the patients with normal D-Dimer (less than 0.55 mg/L). Conclusion D-Dimer is a useful prognostic factor for nasopharyngeal carcinoma. Increased D-Dimer is associated with poor prognosis.

Key words: D-Dimer, Prognosis, Nasopharyngeal carcinoma

中图分类号: 

  • R766.3
[1] 邹丽芳, 朱琦, 程毅敏, 等. 血液系统恶性肿瘤患者止凝血功能的研究[J]. 血栓与止血学, 2013, 19(6):257-260. ZOU Lifang, ZHU Qi, CHENG Yimin, et al. The study of heamostatic function in patients with hematological malignancy[J]. Chin J Thrombosis Hemostasis, 2013, 19(6):257-260.
[2] 许小毛, 王辰. 肿瘤与静脉血栓栓塞症[J]. 中国实用内科杂志, 2013, 33(5):344-347. XU Xiaomao, WANG Chen. Cancer and venous thromboembolism[J]. Chin J Prac Inter Med, 2013, 33(5):344-347.
[3] Olson J D, Cunningham M T, Higgins R A, et al. D-dimer: simple test, tough problems[J]. Arch Pathol Lab Med, 2013, 137(8):1030-1038.
[4] Tripodi A. D-dimer testing in laboratory practice[J]. Clin Chem, 2011, 57(9):1256-1262.
[5] Zhou Y X, Yang Z M, Feng J, et al. High plasma D-dimer level is associated with decreased survival in patients with lung cancer: a meta-analysis[J]. Tumour Biol, 2013, 34(6):3701-3704.
[6] Liu L, Zhang X, Yan B, et al. Elevated plasma d-dimer levels correlate with long term survival of gastric cancer patients[J]. PLoS One, 2014, 9(3):e90547.
[7] 张弘, 刘陶文, 莫碧媛, 等. 鼻咽癌患者血浆D-二聚体水平测定的临床价值[J]. 华夏医学, 2009, 22(1):55-56. ZHANG Hong, LIU Taowen, MO Biyuan, et al. Clinical value of D-Dimer in nasopharyngeal carcinoma[J]. Acta Med Sinica, 2009, 22(1):55-56.
[8] 胡志德, 王璐璐, 赫慧楠. 5种恶性肿瘤患者血浆D二聚体阳性检出率比较[J]. 血栓与止血学, 2006, 12(6):2. HU Zhide, WANG Lulu, HE Huinan. The positive rate of plasma d-dimer in five type patients with malignant tumor[J]. Chin J Thrombosis Hemostasis, 2006, 12(6):2.
[9] Coussens L M, Werb Z. Inflammation and cancer[J]. Nature, 2002, 420(6917):860-867.
[10] Cugno M. Inflammation, coagulation, vascular permeability and thrombosis[J]. Curr Vasc Pharmacol, 2012, 10(5):631.
[1] 刘晓静,王愿,张立庆,冯剑,赵青,宋圣花,周涵,董伟达. 鼻窦骨纤维异常增殖症36例临床分析[J]. 山东大学耳鼻喉眼学报, 2018, 32(2): 73-78.
[2] 吕丹,李明霞,马兰枝,张馨元,肖浩,陈飞,刘均,李珍. 累及纵膈的头颈部丛状I型神经纤维瘤病两例[J]. 山东大学耳鼻喉眼学报, 2018, 32(1): 82-86.
[3] 张彩霞,刘阳云,江文,刘庚勋,曹杭,陈琼,张纪帅. 一氧化氮对鼻咽癌CNE-2细胞株化疗增敏效应的研究[J]. 山东大学耳鼻喉眼学报, 2017, 31(5): 72-78.
[4] 周毅波,龚小蓉,于锋. MiR-150调控Nanog对鼻咽癌侧群细胞增殖、侵袭的影响[J]. 山东大学耳鼻喉眼学报, 2017, 31(5): 79-84.
[5] 陈婷婷,郭其云,刘佳琪,刘丽庭. 探讨同期放化疗对儿童青少年鼻咽癌患者生活质量的影响[J]. 山东大学耳鼻喉眼学报, 2017, 31(2): 55-58.
[6] 于斌,郑青平,罗展雄,李旌,周媛媛,李中华,王磊黎,贺婵娟,石丰榕. 重组人表皮生长因子预防鼻咽癌放射性口腔黏膜炎和急性放射性皮炎的疗效观察[J]. 山东大学耳鼻喉眼学报, 2017, 31(1): 95-99.
[7] 王雅宁,耿博,李百彦,崔朝阳,王启荣. 鼻咽癌放疗后颅底骨感染坏死的治疗体会[J]. 山东大学耳鼻喉眼学报, 2016, 30(6): 42-45.
[8] 谢朝峰,林宏浩. 慢性鼻-鼻窦炎手术预后的临床影响因素分析[J]. 山东大学耳鼻喉眼学报, 2016, 30(4): 90-93.
[9] 马荣峰,朱富高,孙美红,付涛,张晓恒,曹琳. 突发性聋预后的相关因素分析及疗程选择[J]. 山东大学耳鼻喉眼学报, 2016, 30(4): 69-74.
[10] 陈晓红. 遗传型甲状腺髓样癌的精准化治疗[J]. 山东大学耳鼻喉眼学报, 2016, 30(2): 23-27.
[11] 王君影,李晓峰. 小牛血去蛋白提取物眼用凝胶对鼻咽癌放射治疗后眼角膜内皮细胞损伤的影响[J]. 山东大学耳鼻喉眼学报, 2016, 30(1): 76-79.
[12] 赵燕恋, 卢永田, 杨继红, 张娟, 苗芳芳, 李洁萍. 鼻咽癌EGFL7的表达与肿瘤侵袭转移的关系[J]. 山东大学耳鼻喉眼学报, 2015, 29(6): 31-35.
[13] 刘花, 陈贤明. 鼻腔鼻窦胚胎型横纹肌肉瘤2例并相关文献复习[J]. 山东大学耳鼻喉眼学报, 2014, 28(6): 92-95.
[14] 周慧, 黄雪琴, 胡俊丽, 姚俊, 张月飞, 江枫. 黄芩苷对鼻咽癌化疗期间激素使用影响的实验研究[J]. 山东大学耳鼻喉眼学报, 2014, 28(4): 30-32.
[15] 张中华1,王学海2,蔡晓岚3. 鼻咽癌中p-PTEN、p-Akt、p-FoxO1的表达及意义[J]. 山东大学耳鼻喉眼学报, 2014, 28(2): 55-57.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!